MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Effects of deep brain stimulation in genetic parkinsonism

    L. Oliveira, R. Cury, E. Barbosa (Sao Paulo, Brazil)

    Objective: The aim of this systematic review is to explore studies on the effects of DBS in genetic parkinsonism. Background: Therapeutic strategies for Parkinson’s disease…
  • 2017 International Congress

    Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations

    K. Nozile-Firth, V. Viswanathan, K. Foote, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To determine the effects of deep brain stimulation (DBS) on action tremor in Parkinson’s disease (PD) and to identify if there are specific target…
  • 2017 International Congress

    Parkinsonism in the very old – A clinicopathological study

    A. Rajput, E. Rajput (Saskatoon, SK, Canada)

    Objective: To identify, spectrum of Parkinson variants, clinical features and course of disease in age > 80 year onset cases. Background: Old age is the…
  • 2017 International Congress

    Objective identification of freezing of gait in Parkinson’s disease patients using a triaxial accelerometer

    Y. Okuma, H. Mitoma, M. Yoneyama (Izunokuni-city, Japan)

    Objective:  The aim of this study is to objectively detect and quantify freezing of gait (FOG) in Parkinson’s disease (PD) patients during everyday activities.   Background:…
  • 2017 International Congress

    Vitamin D in the Parkinson’s Associated Risk (PARS) Study

    M. Fullard, S. Xie, K. Marek, M. Stern, D. Jennings, A. Siderowf, A. Chen-Plotkin (Philadelphia, PA, USA)

    Objective: The purpose of this study was to evaluate vitamin D levels in a population at risk for developing Parkinson’s disease (PD). Background: Vitamin D…
  • 2017 International Congress

    Gait analysis as a complementary tool in the levodopa dose decision in Vascular Parkinson’s Disease

    M. Gago, F. Ferreira, N. Mollaei, M. Rodrigues, N. Sousa, E. Bicho, P. Rodrigues (Braga, Portugal)

    Objective: Evaluate the role of objective gait analysis in the decision of levodopa dose in VPD, in particular when compared to clinical assessment. Background: Vascular…
  • 2017 International Congress

    Direct dopaminergic responsiveness of activity performance

    P. Hagell, G.-M. Hariz, B. Sandlund (Kristianstad, Sweden)

    Objective: To assess the direct dopaminergic responsiveness of motor and process aspects of activity performance in people with parkinsonian disorders, and to compare this to…
  • 2017 International Congress

    A novel cause for unpredictable response to levodopa

    J. Staisch, G. Bakis, J. Nutt (Portland, OR, USA)

    Objective: [To describe a novel cause for unpredictable response to levodopa] Background: A fluctuating response to levodopa is common in advanced Parkinson’s disease and can…
  • 2017 International Congress

    Neuroticism and depression is associated with impulse control disorder in Parkinson’s disease: a controlled study

    N. Titova, N. Sotnikova, E. Katunina (Moscow, Russian Federation)

    Objective: Cross-sectional assessment of personality trait, impulsivity, depression and anxiety collected prospectively in Parkinson’s disease (PD) with impulse control disorders (PD-ICD) compared to a matched…
  • 2017 International Congress

    Sleep architecture in Parkinson´s disease and Parkinson’s disease associated dementia

    L. Sousa, I. Laranjinha, J. Lopes, J. Ramalheira, A.M. da Silva, A.B. Lima, M. Magalhães (Porto, Portugal)

    Objective: To evaluate the differences in early sleep architecture between patients with Parkinson’s disease (PD) and Parkinson’s disease associated dementia (PDD). Background: Disorders of sleep…
  • « Previous Page
  • 1
  • …
  • 320
  • 321
  • 322
  • 323
  • 324
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley